Our Clients
The pharmaceutical industry comes across significant data availability challenges because of siloed and fragmented sources of data, data privacy concerns, and regulatory constraints. Genomic data, real-word evidence, and clinical trial data are stored often in disparate systems, which interrupts seamless integration.
Data sharing across institutions and borders is often challenging while abiding by regulatory requirements, like GDPR and HIPAA. Moreover, lack of standardized data formats and proprietary data ownership hinder interoperability. These issues prevent making the most of AI and big data, delaying the drug discovery and development process. We are experts in data science and artificial intelligence in pharmaceutical industry, offering advanced data integration technologies, harmonized standards, and collaborative frameworks to mitigate these challenges.
Data in the life sciences industry is highly heterogeneous, originating from diverse sources such as electronic health records, clinical trials, medical imaging, and genomic sequences. It’s challenging to integrate these different data types into a cohesive dataset for analysis by AI.
To enable the integration of diverse datasets, we implement standards such as the Fast Healthcare Interoperability Resources (FHIR). Furthermore, we employ platforms specializing in integrating and harmonizing clinical and multi-omics data for streamlining the process. We leverage AI tools, which can natively handle various data types, such as tools using deep learning for handling multimodal data.
Life sciences data, patient data in particular, often consists of sensitive personal information. Regulations like GDPR in Europe and HIPAA in the U.S. establish strict requirements on how such data can be stored, processed, and shared. This makes it difficult to access large, diverse datasets.
We employ federated learning, which allows the training of AI models across various decentralized data sources without the need to transfer the data to a central server. It facilitates training models on sensitive data, while maintaining the privacy of the data itself. Moreover, we use techniques such as the creation of synthetic datasets or data anonymization to protect individual identities while still supplying valuable data for the training of AI.
We have extensive experience in building custom AI models tailored for the life sciences and pharma industries. In this domain, our expertise ranges over clinical data analysis, proteomics, and genomics, facilitating precise biomarker discovery, personalized medicine, and drug development. Using NLP and machine learning, we provide you with actionable insights to improve patient outcomes and fast track innovation.
Our team is proficient in building custom Large Language Models (LLMs) for the life sciences and pharma industries. Our area of expertise includes regulatory compliance, clinical trial analysis, optimizing for jobs like drug discovery, and model training on specialized biomedical texts. By integrating advanced NLP techniques with domain-specific knowledge, we come up with cutting-edge solutions, which propel innovation and improve decision-making in healthcare.
Over the years, we have achieved expertise in managing DataOps and MLOps for the life sciences and pharma industry. We design solutions to streamline data pipelines, which ensures flawless integration, governance, and transformation of complex biomedical datasets. Deploying scalable MLOps frameworks, we help to automate model development, monitoring, and deployment. This enables rapid iteration and compliance with the industry standards.
Our practical experience in running clinical trials and conducting life sciences research has equipped us with the expertise to generate high-quality data tailored for life sciences and pharma. Our expertise ranges from developing synthetic biomedical datasets, improving real-world data with advanced AI techniques to simulating clinical trials. By ensuring diversity, accuracy, and compliance of data, we empower researchers and companies to fuel innovation in healthcare, improve patient outcomes, and accelerate drug discovery. Furthermore, our data solutions facilitate pharma sales projection, allowing strategic decision-making and more accurate forecasting in a highly competitive market.
Graphic illustrating the use of data science to automate compound screening and accelerate drug discovery in pharma R&D.
Diagram showing how data science and machine learning improve clinical trial efficiency, patient selection, and safety monitoring.
Diagram of AI and data science solutions for optimizing life sciences R&D operations and pharma supply chain management.
Visual representation of big data technologies used for creating and refining personalized medication plans through medical records and genomic data.
Count on the experts. Fill up this form.
No more prolonged waiting times to get a response to your queries. We give you a call within 8 hours of your request. We kick-start your project without any unnecessary delays.
Looking forward to hearing from you!
